Chu Estaing; Hematologie Clinique Adultes

Clermont-Ferrand 63003

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma

Studies at this site

• A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) — Completed
• FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients — Completed